Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Replimune Group, Inc. | 32,000 | reported | 01 Apr 2025 | tx 5+138,700 |
| Vera Therapeutics, Inc. | 17,084 | reported | 21 May 2026 | tx 3+56,084 |
| Karyopharm Therapeutics Inc. | 15,508 | reported | 21 May 2026 | tx 7+203,708 |
| Nuvalent, Inc. | 3,971 | reported | 18 Jun 2025 | tx 2+10,090 |
| RayzeBio, Inc. | 0 | reported | 26 Feb 2024 | tx 1−114,579 |
| LAVA Therapeutics NV | 0 | reported | 13 Nov 2025 | tx 2+33,390−33,390 |
| REATA PHARMACEUTICALS INC | 0 | reported | 26 Sept 2023 | tx 17+29,858−29,858 |
| ProNAi Therapeutics Inc | 0 | reported | 01 Jul 2022 | tx 2+18,000−18,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 15,508 | 0.00 USD | |
| 21 May 2026 | GRANT_AWARD | Vera Therapeutics, Inc. | 17,084 | 0.00 USD | deriv |
| 13 Nov 2025 | OTHER | LAVA Therapeutics NV | 33,390 | 0.00 USD | deriv |
| 18 Jun 2025 | GRANT_AWARD | Nuvalent, Inc. | 3,971 | 0.00 USD | |
| 18 Jun 2025 | GRANT_AWARD | Nuvalent, Inc. | 6,119 | 0.00 USD | deriv |
| 28 May 2025 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 4,600 | 0.00 USD | deriv |
| 14 May 2025 | GRANT_AWARD | Vera Therapeutics, Inc. | 14,000 | 0.00 USD | deriv |
| 01 Apr 2025 | GRANT_AWARD | Replimune Group, Inc. | 32,000 | 0.00 USD | deriv |
| 13 Feb 2025 | GRANT_AWARD | LAVA Therapeutics NV | 33,390 | 0.00 USD | deriv |
| 07 Jun 2024 | GRANT_AWARD | Vera Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 29 May 2024 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 69,000 | 0.00 USD | deriv |
| 01 Apr 2024 | GRANT_AWARD | Replimune Group, Inc. | 32,000 | 0.00 USD | deriv |
| 26 Feb 2024 | OTHER | RayzeBio, Inc. | 114,579 | — | deriv |
| 26 Sept 2023 | OTHER | REATA PHARMACEUTICALS INC | 5,565 | — | |
| 26 Sept 2023 | OTHER | REATA PHARMACEUTICALS INC | 5,620 | — | deriv |
| 26 Sept 2023 | OTHER | REATA PHARMACEUTICALS INC | 5,000 | — | deriv |
| 26 Sept 2023 | OTHER | REATA PHARMACEUTICALS INC | 106 | — | deriv |
| 26 Sept 2023 | OTHER | REATA PHARMACEUTICALS INC | 2,137 | — | deriv |
| 26 Sept 2023 | OTHER | REATA PHARMACEUTICALS INC | 180 | — | deriv |
| 26 Sept 2023 | OTHER | REATA PHARMACEUTICALS INC | 1,250 | — | deriv |
| 26 Sept 2023 | OTHER | REATA PHARMACEUTICALS INC | 10,000 | — | deriv |
| 07 Jun 2023 | GRANT_AWARD | REATA PHARMACEUTICALS INC | 1,682 | 93.61 USD | |
| 07 Jun 2023 | GRANT_AWARD | REATA PHARMACEUTICALS INC | 2,137 | 0.00 USD | deriv |
| 24 May 2023 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 34,000 | 0.00 USD | deriv |
| 01 Apr 2023 | GRANT_AWARD | Replimune Group, Inc. | 25,200 | 0.00 USD | deriv |